Free Trial
→ The chokepoint supplier behind SpaceX's $1.75 trillion empire (From Behind the Markets) (Ad)tc pixel Free DRTSW Stock Alerts

Alpha Tau Medical (DRTSW) Financials

Alpha Tau Medical logo
$0.98 -0.10 (-8.80%)
As of 03:56 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Alpha Tau Medical

Annual Income Statements for Alpha Tau Medical

This table shows Alpha Tau Medical's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -8.37 -8.88 -27 -34 -29 -32 -43
Consolidated Net Income / (Loss)		 -7.56 -8.88 -27 -34 -29 -32 -43
Net Income / (Loss) Continuing Operations		 -8.46 -8.88 -27 -34 -29 -32 -43
Total Pre-Tax Income 		8.32 -8.72 -27 -34 -29 -32 -43
Total Operating Income		 8.01 -9.24 -14 -32 -36 -36 -42
Total Gross Profit		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 8.01 9.24 14 32 36 36 42
Selling, General & Admin Expense		 0.98 1.41 1.86 10 7.33 6.67 8.36
Marketing Expense		 0.40 0.29 0.48 0.97 1.92 2.35 1.86
Research & Development Expense		 6.64 7.54 11 21 26 27 32
Total Other Income / (Expense), net		 0.31 0.52 -13 -1.61 6.54 4.30 -0.22
Other Income / (Expense), net		 0.31 0.52 -13 -1.61 6.54 4.30 -0.22
Income Tax Expense		 -0.15 0.16 0.01 0.02 0.02 0.01 0.12
Basic Earnings per Share		 ($0.25) ($0.22) ($0.67) ($0.53) ($0.42) ($0.45) ($0.53)
Weighted Average Basic Shares Outstanding		 33.82M 40.27M 40.53M 63.53M 69.38M 69.93M 80.58M
Diluted Earnings per Share		 ($0.25) - - ($0.53) ($0.42) ($0.45) ($0.53)
Weighted Average Diluted Shares Outstanding		 33.82M - 66.53M 63.53M 69.38M 69.93M 80.58M
Weighted Average Basic & Diluted Shares Outstanding		 - - 66.53M 69.11M 69.67M 70.38M 88.01M

Quarterly Income Statements for Alpha Tau Medical

No quarterly income statements for Alpha Tau Medical are available.

Annual Cash Flow Statements for Alpha Tau Medical

This table details how cash moves in and out of Alpha Tau Medical's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 5.18 14 7.68 -17 5.97 1.01 -1.52
Net Cash From Operating Activities		 -6.91 -7.25 -12 -24 -18 -20 -27
Net Cash From Continuing Operating Activities		 10 -7.25 -12 -24 -18 -20 -27
Net Income / (Loss) Continuing Operations		 8.46 -8.88 -27 -34 -29 -32 -43
Consolidated Net Income / (Loss)		 8.46 -8.88 -27 -34 -29 -32 -43
Depreciation Expense		 0.07 0.09 0.78 0.98 1.07 1.10 1.23
Non-Cash Adjustments To Reconcile Net Income		 1.55 0.65 14 9.21 10 9.96 11
Changes in Operating Assets and Liabilities, net		 -0.06 0.90 0.59 -0.31 -0.27 1.11 3.49
Net Cash From Investing Activities		 -10 -7.82 19 -90 19 21 -21
Net Cash From Continuing Investing Activities		 -10 -7.82 19 -90 19 21 -21
Purchase of Property, Plant & Equipment		 -1.29 -3.77 -2.93 -0.90 -6.40 -2.24 -6.08
Purchase of Investments		 -54 -70 -8.08 -121 -164 -125 -70
Sale and/or Maturity of Investments		 45 66 30 32 192 148 56
Other Investing Activities, net		 - - 0.00 0.00 -3.15 -0.10 0.00
Net Cash From Financing Activities		 5.32 29 0.11 97 5.30 0.03 46
Net Cash From Continuing Financing Activities		 5.32 29 0.11 97 5.30 0.03 46
Repayment of Debt		 - - - - 0.00 0.00 -5.15
Issuance of Debt		 - - 0.00 0.00 5.25 0.00 5.15
Issuance of Common Equity		 - - - - 0.00 0.00 45
Other Financing Activities, net		 1.02 0.59 0.11 97 0.05 0.03 0.27
Cash Interest Paid		 0.78 0.54 0.00 0.00 0.05 0.32 0.38
Cash Interest Received		 - - 0.35 0.24 6.16 4.42 2.78
Cash Income Taxes Paid		 0.00 0.00 0.00 0.01 0.02 0.01 0.00

Quarterly Cash Flow Statements for Alpha Tau Medical

No quarterly cash flow statements for Alpha Tau Medical are available.

Annual Balance Sheets for Alpha Tau Medical

This table presents Alpha Tau Medical's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 53 42 120 107 86 106
Total Current Assets		 47 33 106 86 64 78
Cash & Equivalents		 16 23 5.84 13 14 12
Restricted Cash		 31 0.62 0.85 3.15 3.26 3.78
Short-Term Investments		 - 8.08 99 69 46 61
Prepaid Expenses		 0.86 0.71 1.10 0.82 1.37 1.40
Plant, Property, & Equipment, net		 5.40 7.55 7.47 13 14 20
Total Noncurrent Assets		 0.14 2.03 6.20 8.36 7.61 7.21
Other Noncurrent Operating Assets		 0.14 2.03 6.20 8.36 7.61 7.21
Total Liabilities & Shareholders' Equity		 53 42 120 107 86 106
Total Liabilities		 7.45 23 14 23 24 29
Total Current Liabilities		 2.09 4.41 4.34 7.10 8.68 11
Accounts Payable		 0.96 4.41 3.67 6.04 7.66 9.38
Other Current Liabilities		 1.12 0.00 0.67 1.06 1.01 1.13
Total Noncurrent Liabilities		 5.37 19 10 16 15 18
Long-Term Debt		 - - 0.00 5.61 5.56 6.35
Other Noncurrent Operating Liabilities		 5.37 19 10 10 9.30 12
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -8.43 -35 106 84 63 77
Total Preferred & Common Equity		 -8.43 -35 106 84 63 77
Total Common Equity		 -8.43 -35 106 84 63 77
Common Stock		 17 18 192 200 210 267
Retained Earnings		 -26 -53 -87 -116 -148 -190

Quarterly Balance Sheets for Alpha Tau Medical

No quarterly balance sheets for Alpha Tau Medical are available.

Annual Metrics And Ratios for Alpha Tau Medical

This table displays calculated financial ratios and metrics derived from Alpha Tau Medical's official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 0.00 0.00 54,268,099.00 69,105,000.00 69,670,612.00 - 69,670,612.00
DEI Adjusted Shares Outstanding		 0.00 0.00 54,268,099.00 69,105,000.00 69,670,612.00 - 69,670,612.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 0.00 -0.50 -0.49 -0.42 - -0.61
Growth Metrics		 - - - - - - -
Profitability Metrics		 - - - - - - -
Net Operating Profit after Tax (NOPAT)		 8.15 -6.47 -9.65 -22 -25 -25 -30
Return On Investment Capital (ROIC_SIMPLE)		 - - - -21.29% -27.72% -36.98% -35.47%
Earnings before Interest and Taxes (EBIT)		 8.32 -8.72 -27 -34 -29 -32 -43
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 8.38 -8.64 -26 -33 -28 -31 -41
Valuation Ratios		 - - - - - - -
Leverage & Solvency		 - - - - - - -
Liquidity Ratios		 - - - - - - -
Cash Flow Metrics		 - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -5.41 2.04 -36 -29 -25 -31
Efficiency Ratios		 - - - - - - -
Capital & Investment Metrics		 - - - - - - -
Invested Capital		 0.00 -1.06 -13 0.28 4.67 4.94 6.17
Increase / (Decrease) in Invested Capital		 0.00 -1.06 -12 13 4.40 0.27 1.23
Book Value per Share		 $0.00 ($0.21) ($0.86) $0.87 $1.22 $0.90 $0.96
Tangible Book Value per Share		 $0.00 ($0.21) ($0.86) $0.87 $1.22 $0.90 $0.96
Total Capital		 0.00 46 19 106 90 68 83
Total Debt		 0.00 0.00 0.00 0.00 5.61 5.56 6.35
Total Long-Term Debt		 0.00 0.00 0.00 0.00 5.61 5.56 6.35
Net Debt		 0.00 -47 -32 -105 -79 -57 -71
Capital Expenditures (CapEx)		 1.29 3.77 2.93 0.90 6.40 2.24 6.08
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -1.22 -3.70 -3.24 -6.29 -7.30 -9.11
Debt-free Net Working Capital (DFNWC)		 0.00 45 28 102 79 56 68
Net Working Capital (NWC)		 0.00 45 28 102 79 56 68
Net Nonoperating Expense (NNE)		 16 2.41 18 11 4.18 6.52 13
Net Nonoperating Obligations (NNO)		 0.00 -47 -32 -105 -80 -58 -71
Total Depreciation and Amortization (D&A)		 0.07 0.09 0.78 0.98 1.07 1.10 1.23
Earnings Adjustments		 - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($0.67) ($0.53) ($0.42) ($0.45) ($0.53)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 40.53M 63.53M 69.38M 69.93M 80.58M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($0.67) $0.00 $0.00 ($0.45) ($0.53)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 40.53M 69.11M 69.67M 69.93M 80.58M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 66.53M 69.11M 69.67M 70.38M 88.01M
Normalized Net Operating Profit after Tax (NOPAT)		 5.61 -6.47 -9.65 -22 -25 -25 -30
Debt Service Ratios		 - - - - - - -
Payout Ratios		 - - - - - - -

Quarterly Metrics And Ratios for Alpha Tau Medical

No quarterly metrics and ratios for Alpha Tau Medical are available.


Financials Breakdown Chart

Frequently Asked Questions About Alpha Tau Medical's Financials

When does Alpha Tau Medical's fiscal year end?

According to the most recent income statement we have on file, Alpha Tau Medical's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

How has Alpha Tau Medical's net income changed over the last 6 years?

Alpha Tau Medical's net income appears to be on an upward trend, with a most recent value of -$42.63 million in 2025, rising from -$7.56 million in 2019. The previous period was -$31.75 million in 2024.

What is Alpha Tau Medical's operating income?
Alpha Tau Medical's total operating income in 2025 was -$42.29 million, based on the following breakdown:
  • Total Gross Profit: $0.00
  • Total Operating Expenses: $42.29 million
How has Alpha Tau Medical's revenue changed over the last 6 years?

Over the last 6 years, Alpha Tau Medical's total revenue changed from $0.00 in 2019 to $0.00 in 2025, a change of 0.0%.

How much debt does Alpha Tau Medical have?

Alpha Tau Medical's total liabilities were at $28.55 million at the end of 2025, a 21.3% increase from 2024, and a 283.1% increase since 2020.

How much cash does Alpha Tau Medical have?

In the past 5 years, Alpha Tau Medical's cash and equivalents has ranged from $5.84 million in 2022 to $23.24 million in 2021, and is currently $12.20 million as of their latest financial filing in 2025.

How has Alpha Tau Medical's book value per share changed over the last 6 years?

Over the last 6 years, Alpha Tau Medical's book value per share changed from 0.00 in 2019 to 0.96 in 2025, a change of 95.7%.


Related Companies

Financial statements for NASDAQ:DRTSW last updated on 5/1/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel
Invest in SpaceX Before IPO
SpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation...
NXT Wave Research | Sponsoredtc pixel
URGENT: $2 Gold Stock With Major Discovery
A $2 gold stock is said to quietly control what may be the largest gold deposit in the world - worth nearly $1...
Paradigm Press | Sponsoredtc pixel